XML 130 R114.htm IDEA: XBRL DOCUMENT v3.25.0.1
BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Divestiture (Details) - USD ($)
$ in Thousands
 12 Months Ended
Aug. 02, 2022
Dec. 31, 2024
Dec. 31, 2023
Noncash or Part Noncash Divestitures [Line Items]      
Contract with Customer, Asset, after Allowance for Credit Loss   $ 25,900 $ 41,700
Contract with Customer, Receivable, after Allowance for Credit Loss   56,600 31,600
Other long-term assets      
Noncash or Part Noncash Divestitures [Line Items]      
Contract with Customer, Receivable, after Allowance for Credit Loss   28,700  
Other Current Assets      
Noncash or Part Noncash Divestitures [Line Items]      
Contract with Customer, Receivable, after Allowance for Credit Loss   27,900  
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Oncotype DX Genomic Prostate Score Test      
Noncash or Part Noncash Divestitures [Line Items]      
Cash $ 25,000    
MDxHealth American Depository Shares 4,631    
Contingent consideration 0    
Total consideration $ 29,631    
Disposal Group, Contingent Consideration Arrangements, Additional Consideration     3,100
Disposal Group, Contingent Consideration Arrangements, Gain (Loss)   $ 9,200 $ 73,300